GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BTG PLC (OTCPK:BTGGF) » Definitions » FCF Margin %

BTG (BTGGF) FCF Margin % : 18.00% (As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is BTG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BTG's Free Cash Flow for the six months ended in Mar. 2019 was $75.3 Mil. BTG's Revenue for the six months ended in Mar. 2019 was $418.4 Mil. Therefore, BTG's FCF Margin % for the quarter that ended in Mar. 2019 was 18.00%.

As of today, BTG's current FCF Yield % is 2.78%.

The historical rank and industry rank for BTG's FCF Margin % or its related term are showing as below:

BTGGF' s FCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 12.31
Current: 12.31


During the past 13 years, the highest FCF Margin % of BTG was 12.31%. The lowest was 0.00%. And the median was 0.00%.

BTGGF's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -148.935 vs BTGGF: 12.31


BTG FCF Margin % Historical Data

The historical data trend for BTG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BTG FCF Margin % Chart

BTG Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.87 14.55 11.34 17.15 12.31

BTG Semi-Annual Data
Sep09 Mar10 Sep10 Mar11 Sep11 Mar12 Sep12 Mar13 Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.40 21.71 11.85 7.50 18.00

Competitive Comparison of BTG's FCF Margin %

For the Biotechnology subindustry, BTG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTG's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BTG's FCF Margin % falls into.



BTG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BTG's FCF Margin for the fiscal year that ended in Mar. 2019 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2019 )/Revenue (A: Mar. 2019 )
=112.5/914.1
=12.31 %

BTG's FCF Margin for the quarter that ended in Mar. 2019 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2019 )/Revenue (Q: Mar. 2019 )
=75.3/418.4
=18.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BTG FCF Margin % Related Terms

Thank you for viewing the detailed overview of BTG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BTG (BTGGF) Business Description

Traded in Other Exchanges
N/A
Address
5 Fleet Place, London, GBR, EC4M 7RD
BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.